Feline Acute Kidney Injury

Feline Acute Kidney Injury (AKI) is a rapidly developing syndrome characterized by injury to the renal parenchyma, with or without a decrease in kidney function, as reflected by accumulation of uremic toxins or altered urine production [1]. Unlike chronic kidney disease (CKD), AKI develops over hours to days and may be potentially reversible if identified early and managed aggressively [3]. It represents one of the most frequently recognized and life-threatening urological emergencies in cats, arising from ischemic, toxic, inflammatory, or infectious insults to the kidneys [3]. Importantly, AKI and CKD are not always mutually exclusive — episodes of AKI can occur on a background of pre-existing CKD (termed "AKI on CKD"), and AKI that fails to fully resolve may itself contribute to the progression of chronic kidney disease [6].

Major Etiological Categories

AKI in cats results from diverse insults that can be broadly grouped into prerenal, intrinsic (renal), and postrenal causes [1][3].

1. Prerenal AKI Prerenal azotemia arises from reduced renal perfusion without primary parenchymal injury — causes include dehydration, hemorrhage, hypotension, cardiac failure, and anesthesia-related hypoperfusion. If perfusion is not restored promptly, ischemic injury to tubular cells rapidly converts prerenal azotemia into true intrinsic AKI [3].

2. Intrinsic (Renal) AKI

• ·

  Ischemic AKI: Prolonged hypoperfusion damages the tubular epithelium, particularly the highly metabolically active proximal tubular cells. Ischemia triggers cellular ATP depletion, mitochondrial dysfunction, cytoskeletal disruption, and ultimately tubular cell necrosis or apoptosis. Tubular debris causes intraluminal obstruction, and cellular swelling reduces glomerular filtration [3].

• ·

  Nephrotoxic AKI: A leading cause in cats. Ethylene glycol (antifreeze) is one of the most devastating nephrotoxins — it is metabolized to glycolic and oxalic acids, which combine with calcium to form calcium oxalate crystals that precipitate within renal tubules, causing direct tubular injury, inflammation, and obstruction [3][4]. NSAIDs (notably meloxicam) are an important and increasingly documented cause; prostaglandin inhibition reduces afferent arteriolar vasodilation, critically reducing GFR particularly in patients with compromised renal perfusion [5]. A case series identified 18 cats developing AKI following subcutaneous meloxicam administration [5]. Other nephrotoxins include aminoglycoside antibiotics (e.g., gentamicin), lily plant ingestion (Lilium and Hemerocallis spp. — a uniquely feline nephrotoxin), contrast agents, and heavy metals [3][4].

• ·

  Infectious/Inflammatory AKI: Pyelonephritis (ascending bacterial infection) is common; leptospirosis, though less prevalent than in dogs, is a recognized cause. Feline infectious peritonitis (FIP) can cause granulomatous nephritis. Immune-mediated glomerulonephritis from various infectious or inflammatory diseases may precipitate AKI [3].

• ·

  Obstructive AKI (Postrenal): Ureteral obstruction — increasingly recognized in cats, often due to ureterolithiasis (calcium oxalate ureteroliths) or ureteral strictures — can cause acute obstructive nephropathy. Urethral obstruction causing postrenal azotemia is another common presentation in male cats [3][4].

• ·

  Hospital-Acquired AKI: An underappreciated category in veterinary medicine, now increasingly recognized. Perioperative hypotension, nephrotoxin exposure during hospitalization, and sepsis are important contributors [1].

Pathophysiological Mechanisms

The final common pathway in most forms of AKI involves:

1. ·Tubular epithelial cell injury — necrosis or apoptosis of proximal tubular cells leads to backleak of filtrate and intraluminal obstruction [3]
2. ·Microvascular dysfunction — endothelial injury causes vasoconstriction, impaired autoregulation, and reduced peritubular capillary flow [3]
3. ·Inflammatory amplification — release of damage-associated molecular patterns (DAMPs) activates innate immune pathways, further propagating injury beyond the initial insult [1][3]
4. ·Reduced GFR — the cumulative result of tubular obstruction, afferent vasoconstriction, and interstitial edema [3]

Hyperammonemia has been documented in azotemic cats with AKI and correlates with indices of worsening renal function, potentially contributing to neurological manifestations independently of hepatic disease [8].

Clinical Presentation and History

A thorough history — including potential toxin exposure (lilies, ethylene glycol, NSAIDs, aminoglycosides), recent anesthesia or procedures, urination habits, and vaccination status — is essential [3][4]. Physical examination findings such as painful renomegaly, oral ulcers, dehydration, and altered mentation strongly support AKI [3].

Serum Biochemistry

• ·BUN (Blood Urea Nitrogen) and CREA (Creatinine): The cornerstone of azotemia assessment. Elevations confirm reduced GFR; however, these markers are insensitive — significant nephron loss must occur before values rise above reference range. BUN is also influenced by dietary protein intake and catabolism [3][4]
• ·Symmetric Dimethylarginine (SDMA): A more sensitive marker of GFR reduction; rises earlier than creatinine, though it is not AKI-specific [6]
• ·Phosphorus: Hyperphosphatemia is common in AKI due to reduced renal excretion [3]
• ·Potassium: Hyperkalemia is a life-threatening complication of oliguric/anuric AKI and requires immediate intervention. Conversely, hypokalemia can occur in polyuric phases or with vomiting/anorexia [3][4]
• ·Bicarbonate/Total CO₂: Metabolic acidosis is typical, resulting from failure to excrete hydrogen ions and generate bicarbonate [3]
• ·ALT (Alanine Aminotransferase): May be elevated concurrent with hepatic involvement, particularly in systemic disease or leptospirosis [3]
• ·Calcium: Hypercalcemia or hypocalcemia may be present depending on etiology; ethylene glycol toxicity classically causes severe hypocalcemia due to calcium oxalate deposition [3]
• ·ALB (Albumin): Hypoalbuminemia may reflect protein-losing nephropathy (glomerulonephritis) or concurrent systemic illness [3][4]
• ·TBIL (Total Bilirubin): Assessed to identify concurrent hepatic involvement or cholestasis [3]

Complete Blood Count (CBC)

• ·HCT/PCV: Anemia of variable severity may be present (non-regenerative in early AKI; hemoconcentration may mask anemia initially). Severe anemia reduces oxygen delivery and exacerbates ischemic renal injury [3]
• ·WBC: Leukocytosis with a neutrophilic left shift suggests sepsis, pyelonephritis, or leptospirosis. Leukopenia may indicate severe sepsis [3]
• ·PLT (Platelets): Thrombocytopenia may occur with leptospirosis, DIC, or IMHA concurrent with AKI [3]

Urinalysis and Urine Culture

Urinalysis is essential: isosthenuria or minimally concentrated urine (USG < 1.030 in cats) in the face of azotemia suggests intrinsic renal failure rather than prerenal azotemia. Active urine sediment — granular casts, renal epithelial cells, crystalluria (calcium oxalate monohydrate crystals in ethylene glycol toxicity), pyuria, and bacteriuria — provides etiological clues [3][4]. Urine culture is mandatory to exclude pyelonephritis [3].

Novel Biomarkers

Urinary biomarkers — including neutrophil gelatinase-associated lipocalin (NGAL), clusterin, and cystatin B — can detect tubular injury prior to creatinine elevation, offering earlier diagnosis opportunities, though their clinical availability is limited [1][6].

Imaging

• ·Abdominal ultrasonography: Provides critical information about kidney size, echogenicity, architecture (cortical-medullary definition), presence of hydronephrosis, ureteral or renal pelvis dilation, uroliths, and perirenal fluid. Hyperechoic cortices in cats strongly suggest ethylene glycol toxicity [3][4]
• ·Radiography: Useful for detecting radiodense uroliths and assessing kidney size [4]

IRIS AKI Grading

The International Renal Interest Society (IRIS) has established a grading system (Grades I–V) for AKI severity based on creatinine concentration and urine output, enabling standardized communication, prognostication, and treatment escalation decisions [1].

Ethylene Glycol Testing

Serum or urine ethylene glycol test kits should be used urgently in any cat with suspected toxin exposure, given the narrow therapeutic window (treatment must commence within hours of ingestion) [3][4].

Emergency Stabilization

Initial management focuses on correcting life-threatening abnormalities: severe hyperkalemia (cardiac arrhythmias), metabolic acidosis, and dehydration/hypovolemia [1][3][4].

Fluid Therapy

Intravenous fluid therapy is the foundation of AKI management [3][4]:

• ·Volume resuscitation: Crystalloids (e.g., 0.9% NaCl or Lactated Ringer's) administered to correct deficits and restore renal perfusion
• ·Maintenance and ongoing losses: Fluid rates tailored to urine output, insensible losses, and clinical status; close monitoring of body weight, urine output, and clinical hydration is essential
• ·Caution with overhydration: Fluid overload in oliguric/anuric cats can be life-threatening; central venous pressure monitoring or urinary catheterization to measure output is strongly recommended in severe cases [1][4]

Management of Oliguria/Anuria

In cats failing to respond to fluid resuscitation [3][4]:

• ·Furosemide: Loop diuretic to promote urine flow; does not alter the course of AKI but may convert oliguric to non-oliguric AKI
• ·Mannitol: Osmotic diuretic; also has antioxidant and vasodilatory properties; use cautiously in volume-overloaded patients
• ·Dopamine: Historically used at "renal doses" for vasodilation; evidence in cats is not robust, but may be used as adjunctive therapy

Electrolyte and Acid-Base Correction

• ·Hyperkalemia: Calcium gluconate (cardioprotection), insulin + dextrose (cellular K⁺ shift), sodium bicarbonate (alkalinization shifts K⁺ intracellularly) [3][4]
• ·Metabolic acidosis: Sodium bicarbonate supplementation when pH < 7.1 or bicarbonate < 12 mEq/L [3]
• ·Hypokalemia: Potassium supplementation in IV fluids in polyuric phases [3]

Etiology-Specific Treatments

• ·Ethylene glycol toxicity: Fomepizole (4-methylpyrazole; less effective in cats than dogs) or ethanol as antidotes — must be administered within hours of ingestion; dialysis is often required in cats [3][4]
• ·Pyelonephritis: Culture-directed antibiotic therapy (fluoroquinolones or amoxicillin-clavulanate initially, adjusted based on sensitivity) for 4–6 weeks [3]
• ·NSAID-induced AKI: Immediate discontinuation; aggressive fluid support [5]
• ·Ureteral obstruction: Surgical intervention (ureterotomy, ureteral reimplantation) or interventional procedures (subcutaneous ureteral bypass, ureteral stenting) [3][4]
• ·Lily toxicity: No antidote; intensive fluid diuresis initiated within hours of ingestion [3]

Nutritional Support

Uremic cats are often anorexic and catabolic. Enteral nutrition via nasogastric or esophagostomy tubes is preferred. Renal-specific diets with reduced protein, phosphorus, and sodium may be instituted once the acute phase is controlled, though adequate caloric intake takes priority over dietary restriction in the acute phase [4].

Renal Replacement Therapy (RRT) / Hemodialysis

When medical management fails to control uremia, fluid overload, severe electrolyte disturbances, or intractable oliguria/anuria, intermittent hemodialysis (IHD) or peritoneal dialysis should be considered [2][4]. IHD expands the "window of opportunity" for renal recovery by controlling the consequences of uremia while the kidneys heal [2]. Extracorporeal therapies are particularly valuable for toxin removal (e.g., ethylene glycol, aminoglycosides) and for severe AKI grades IV–V on the IRIS scale [1][2]. Peritoneal dialysis is more widely accessible in general practice settings and can be life-saving when IHD is unavailable [4].

Monitoring

Hospitalized cats with AKI require intensive monitoring including serial measurement of BUN, creatinine, electrolytes, blood pressure, urine output (via urinary catheter in severe cases), body weight, and ECG monitoring in cats with hyperkalemia [1][4].

Feline AKI carries a guarded to poor prognosis, with reported mortality rates varying substantially by etiology, severity, and treatment modality [7].

Overall Mortality

A proportional meta-analysis of case series studies in cats and dogs with AKI found that mortality in cats is significant and highly etiology-dependent [7]. Across studies, cats with AKI had mortality rates broadly ranging from approximately 40% to over 60% depending on cause and access to advanced care [7]. Cats receiving dialysis had different survival outcomes compared to those managed conservatively, with dialysis expanding treatment options in otherwise refractory cases [2][7].

Etiology-Specific Outcomes

• ·Ethylene glycol toxicity: Carries one of the worst prognoses; cats diagnosed and treated very early may survive, but many present in irreversible acute tubular necrosis, with mortality extremely high — many sources report survival rates below 10–20% once clinical signs are present [3][7]
• ·Lily toxicity: Prognosis is grave if treatment is delayed beyond 18 hours post-ingestion; with early, aggressive fluid diuresis, survival is possible [3]
• ·Pyelonephritis: Relatively better prognosis with appropriate antibiotic therapy; however, sepsis-associated AKI carries higher mortality [3][7]
• ·NSAID-associated AKI: Prognosis is variable; some cats recover with supportive care, but severe cases can result in death or progression to CKD [5]
• ·Obstructive AKI (ureteral obstruction): Prognosis depends heavily on duration of obstruction and degree of pre-existing renal dysfunction; relief of obstruction can result in substantial recovery if performed promptly [3]

Prognostic Indicators

Poor prognostic factors include [3][4][7]:

• ·Oliguria or anuria persisting despite fluid resuscitation
• ·Very high creatinine concentrations (IRIS AKI Grade IV–V)
• ·Severe hyperkalemia, severe metabolic acidosis
• ·Hypothermia at presentation
• ·Hyperammonemia correlating with worsening azotemia [8]
• ·Requirement for dialysis (reflects severity, though dialysis also improves outcomes in appropriate candidates) [2]

AKI-to-CKD Progression

Cats that survive AKI are at substantial risk of developing CKD, as repeated or severe tubular injury promotes interstitial fibrosis and permanent nephron loss [6]. The relationship between AKI and CKD is bidirectional — each condition predisposes to the other [6].

Toxin Avoidance

• ·Lily plants (Lilium spp., Hemerocallis spp.) should be strictly excluded from households with cats; even small ingestions (pollen, leaves, water from vases) can be fatal [3]
• ·Ethylene glycol (antifreeze): Store securely and clean spills immediately; consider pet-safe propylene glycol-based alternatives [3]
• ·NSAIDs: Use with extreme caution in cats — NSAIDs should only be administered at the lowest effective dose for the shortest duration, and are contraindicated in dehydrated, hypotensive, or renally compromised cats; pre-treatment renal function assessment is strongly recommended [5]
• ·Aminoglycoside antibiotics: Avoid or use with therapeutic drug monitoring and renal function assessment; ensure adequate hydration [3]

Minimizing Perioperative and Hospital-Acquired AKI

• ·Maintain adequate blood pressure and intravascular volume during anesthesia; treat hypotension promptly [1]
• ·Avoid concurrent use of nephrotoxic drugs in hospitalized patients [1]
• ·Monitor renal biomarkers in high-risk hospitalized patients to enable early detection [1][6]

Management of Pre-existing CKD

Cats with CKD are at heightened risk of AKI episodes; maintaining optimal hydration, avoiding nephrotoxins, and regular veterinary monitoring of renal values can reduce this risk [6].

Early Detection and Veterinary Monitoring

Regular wellness examinations with serum chemistry panels (including BUN, CREA, SDMA) in middle-aged to senior cats allow detection of early renal dysfunction and identification of risk factors before AKI develops [6]. Owner education about early warning signs (anorexia, lethargy, vomiting, changes in urination) enables earlier presentation and intervention [3][4].